您的位置: 首页 > 农业专利 > 详情页

VARIANTES DE L'INTERFERON .ALPHA.2.BETA.
专利权人:
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
发明人:
BEHRENS, COLLETTE,DOYLE, ANTHONY,CLARKE, ADAM,POLLARD, MATTHEW,DOMAGALA, TERESA
申请号:
CA2965414
公开号:
CA2965414A1
申请日:
2015.10.23
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
The present invention provides a fusion polypeptide comprising a first domain and a second domain, wherein the first domain comprises a polypeptide ligand which binds to a cell surface-associated antigen and the second domain comprises aglycosylated interferon a 2b (IFNa2b) having a sequence of SEQ ID NO: 1 or SEQ ID NO: 2. The aglycosylated IFNa2b further comprises one or more amino acid substitutions or deletions which attenuate the activity of the aglycosylated IFNa2b.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充